Lessons From HyTEC: Brain Necrosis, Optic Neuropathy and Brachial Plexopathy After Stereotactic Radiotherapy
HyTEC (Hypo-fractionated or “Hy”-dose per fraction, Treatment Effects in the Clinic) was an American Association of Physicists in Medicine-led initiative focusing on hypofractionated SBRT/SABR and stereotactic radiosurgery in adults.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Managing Radiotherapy-Induced Symptoms: Practical Evidence-Based Strategies for the Radiation Oncologist
Managing symptoms induced by radiotherapy is an important component of radiation oncology practice.
Category
  • General RO
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Emerging Indications for Radiation in Poly-Metastatic Cancers
This activity focuses on new and emerging indications for radiation in patients with metastatic cancers.
Category
  • Immunotherapy
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Attendance
Cost $149.00
Liquid Biopsies in Cancer
Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.
Category
  • General RO
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Integration of Minimally Invasive Interventional Procedures with Palliative Radiation Therapy
Symptoms from cancer are often best palliated by multimodal therapies performed by different physicians.
Category
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Raising the Bar and Lowering Uncertainties in Reirradiation
With technological advances re-irradiation has rapidly become common and an important part of cancer management to new or recurrent tumors, yet is clinically challenging given risks of serious toxicity from cumulative doses.
Category
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Bringing Rationalism to Empiricism: A Discussion on Empiric SBRT for Early-Stage Lung Cancer
Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $149.00
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
  • Professional Development
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Over the last 10 years, new studies have emerged demonstrating efficacy and safety of re-irradiation for children with recurrent brain tumors.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages